1. Home
  2. List
Reference Patent

Reference - List

  • 102 Hits
  • 検索条件 : 絞込み (MeSH = Neoplasms / genetics)
Species Resource Title
Mice RBRC01361 Pathological Relationship between Intracellular Superoxide Metabolism and p53 Signaling in Mice.
Human and Animal Cells HuH-6(RCB1367) Cysteamine dioxygenase (ADO) governs cancer cell mitochondrial redox homeostasis through proline metabolism.
Human and Animal Cells HeLa(RCB0007) , 293T(RCB2202) Pax5 mediates the transcriptional activation of the CD81 gene.
Human and Animal Cells TT1TKB(RCB1185) Targeting ALDH1A1 to enhance the efficacy of KRAS-targeted therapy through ferroptosis.
Drosophila 4005R-2 Blockade of Crk eliminates Yki/YAP-activated tumors via JNK-mediated apoptosis in Drosophila.
DNA material CSII-CMV-MCS-IRES2-Bsd (RDB04385) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) Development of Human CBF1-Targeting Single-Stranded DNA Aptamers with Antiangiogenic Activity In Vitro.
Human and Animal Cells NOS-2(RCB1033) , HuO-3N1(RCB2104) , HuO 9N2 (O9N2)(RCB2532) , MG-63(RCB190) , NOS-1(RCB1032) Cytochrome P450 2J2 is required for the natural compound austocystin D to elicit cancer cell toxicity.
Mice RBRC02759 Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation.
Human and Animal Cells Lu99(RCB1900) The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading.
Human and Animal Cells HUDEP-2(RCB4557) Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase.
Human and Animal Cells KP4(RCB1005) MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage.
Human and Animal Cells II-18(RCB2093) Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors.
Human and Animal Cells EBC-1(RCB1965) PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity.
Human and Animal Cells NIH3T3-3-4(RCB1862) Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope.
Human and Animal Cells A549(RCB0098) , HeLa(RCB0007) DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotency.
Human and Animal Cells EBC-1(RCB1965) , A549 , HSC-4(RCB1902) , LU65(RCB1967) A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy.
Yeast FY11064(MY3141) , FY10067(MY2167) Expression of the cancer-associated DNA polymerase ε P286R in fission yeast leads to translesion synthesis polymerase dependent hypermutation and defective DNA replication.
Human and Animal Cells C2C12(RCB0987) , B16F10(RCB2630) Extracellular acidity in tumor tissue upregulates programmed cell death protein 1 expression on tumor cells via proton-sensing G protein-coupled receptors.
Human and Animal Cells Ba/F3 Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17.
Human and Animal Cells B16F10(RCB2630) Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines.